The Seventh Schedule of the Cosmetics Rules 2020 is the sole GMP standard for cosmetics manufacturing in India. COS-8 grant and renewal are both conditioned on Seventh Schedule compliance under Rule 26(b). This page sets out what the schedule requires, how the State Licensing Authority verifies it, and what foreign manufacturers must demonstrate for import registration.
Every cosmetics manufacturing license issued in India — the COS-8 granted by the State Licensing Authority — is conditioned on compliance with the Seventh Schedule of the Cosmetics Rules 2020. Rule 26(b) makes this explicit: factory premises must comply with the requirements and conditions specified in the Seventh Schedule as a standing condition of holding the license. Failure at any point is grounds for suspension or cancellation.
The Seventh Schedule supersedes Schedule M-II, which governed cosmetics GMP under the Drugs and Cosmetics Rules 1945. The Thirteenth Schedule, Clause 22 of the Cosmetics Rules 2020 formally omitted Schedule M-II. Any reference to Schedule M in the context of cosmetics manufacturing is legally incorrect.
This page sets out what the Seventh Schedule requires, how compliance is assessed at the time of COS-8 application, how the State Licensing Authority verifies it post-grant, and what GMP evidence foreign manufacturers must provide for import registration.
The Seventh Schedule is divided into two parts.
Part I — General Requirements covers the operating environment and management systems applicable to all cosmetics manufacturers regardless of product category. It is structured under eleven clauses:
Part II — Requirements of Plant and Equipment specifies the minimum floor area (in square metres) and the equipment required for each cosmetics manufacturing category — Categories A through L. The categories span:
The minimum area and equipment specifications vary by category. A manufacturer must satisfy the Part II requirements for every category listed on their COS-8.
The Seventh Schedule states broadly that personnel must have experience and capabilities relevant to their assigned function. Rule 26(a) sets the specific minimum qualification for the person responsible for manufacturing supervision: they must be a whole-time employee and must hold at least one of the following:
This person must be on site during manufacturing operations and is personally accountable for GMP compliance. A manufacturer who cannot demonstrate the presence of a qualifying technical person fails a basic license condition.
The Seventh Schedule itself references documentation in Clause I(H) (equipment calibration records) and Clause I(I) (SOPs and testing records). The comprehensive batch documentation obligations sit in Rule 26 and the Eighth Schedule.
Rule 26(f) requires the licensee to maintain records of every batch manufactured, including raw materials used, in the format specified by the Eighth Schedule. These records must be retained for three years after the date of batch expiry — not three years from the date of manufacture.
Rule 26(h) requires separate registers for testing of raw materials and finished products. These registers must be available for inspection by the State Licensing Authority at any time.
The combined documentation system — Form COS-7 self-declaration at application, batch records per the Eighth Schedule, testing registers under Rule 26(h), and calibration records under Schedule VII Clause I(H) — constitutes the minimum documentation framework a COS-8 licensee must maintain.
The Cosmetics Rules 2020 operate on a self-declaration model at the point of COS-8 grant. Rule 23(4) requires the applicant to submit Form COS-7, which is a self-declaration confirming compliance with the Seventh Schedule — premises, plant, equipment, and the general requirements of Part I.
Rule 23(5) requires the State Licensing Authority to grant or refuse the COS-8 within 45 days of receiving the application, based on document scrutiny. There is no mandatory pre-grant site inspection. The license is issued on the strength of the submitted documents and the Form COS-7 self-declaration.
Verification of the self-declaration occurs after the license is issued. Rule 23(7) requires the State Licensing Authority to inspect the manufacturing site — or authorise another officer to do so — within 30 days of COS-8 grant. The purpose of this inspection is to verify the information given in Form COS-7 against actual site conditions.
If the inspection reveals that conditions do not match the self-declaration, the State Licensing Authority has grounds to suspend or cancel the COS-8 under the applicable provisions of the Rules. Periodic inspections occur every three years for continuing licensees.
The 30-day inspection window means that manufacturers must be in full Seventh Schedule compliance at the point of application — not just at the point of inspection. Remediation between grant and inspection does not cure a false self-declaration.
For import registration, the Cosmetics Rules 2020 do not impose the Seventh Schedule directly on foreign manufacturing sites. The applicable standard is set by Rule 3(b), which defines an actual manufacturer as one whose site is approved by the National Regulatory Authority or competent authority in the country of origin.
This approval is evidenced through the Second Schedule, Part-I, Clause 2(b), which requires the importer to submit manufacturing licenses, marketing authorisations, or free-sale certificates issued by the regulatory authority of the country of origin. The Rules do not specify WHO-GMP as the required standard; site approval by a recognised national authority is the accepted basis for import registration.
A WHO-GMP certificate issued by a recognised authority and covering the specific manufacturing site is accepted in practice where it constitutes the relevant national regulatory approval. Site-specific coverage is critical — a WHO-GMP certificate that does not name the actual manufacturing facility is insufficient.
Rule 26(b) makes Seventh Schedule compliance a continuing condition, not a one-time requirement at the point of grant. COS-8 renewal requires the same demonstration of compliance. A facility that has allowed its GMP systems to lapse — outdated calibration records, unqualified technical staff, or premises that no longer meet Part II specifications — faces refusal of renewal in addition to potential suspension of the existing license.
Contractors and loan licensees operating under COS-9 are subject to equivalent obligations: the manufacturing facility used must meet Seventh Schedule requirements, and the loan licensee retains responsibility for ensuring those conditions are met.
Cosmetics Consultants India advises manufacturers on Seventh Schedule compliance assessments, Form COS-7 preparation, and COS-8 applications. Contact us to confirm your site meets the requirements before application.
COS-8 is the manufacturing license required under Rule 23 of the Cosmetics Rules 2020 for any person manufacturing cosmetics for sale or distribution in India. Issued by the State Licensing Authority, it is valid in perpetuity subject to 5-yearly retention fees.
Learn more →COS-8 manufacturing licenses are issued by the State Licensing Authority under Rule 23(1) of the Cosmetics Rules, 2020. This page covers the application process, Seventh Schedule GMP requirements, fees, validity, and the 2025 amendments.
Learn more →Schedule M-II was omitted by Thirteenth Schedule, Clause 22 of the Cosmetics Rules 2020. The Seventh Schedule is the current GMP standard for cosmetics manufacturing in India, operative through Rule 23(4) and Rule 26(b).
Learn more →Want to learn more?
Our blog covers Manufacturing Licensing topics in depth — guides, checklists, and regulatory updates.